Controversies in Stable Chronic Coronary Syndromes – ISCHEMIA and Beyond
Cardiovascular Research Foundation
34 videos
The Cardiovascular Research Foundation is a pre-eminent force in the progress against cardiovascular disease and, for nearly 30 years, a proven partner for researchers, physicians, and related...
Read More
The Cardiovascular Research Foundation is a pre-eminent force in the progress against cardiovascular disease and, for nearly 30 years, a proven partner for researchers, physicians, and related health professionals.
Speakers
Works at Yale University, Internal Medicine, Section of Cardiology. Features in 1 video on Wondr Medical. Assistant...
Works at Yale University, Internal Medicine, Section of Cardiology. Features in 1 video on Wondr Medical. Assistant Professor E Spatz generally speaks on Dobutamine Stress Echo (DSE), Stable Coronary Artery Disease (CAD), and Positron Emission Tomography (PET).
Works at Mayo Clinic, Rochester, MN, USA. Features in 1 video on Wondr Medical. Bernard Gersh generally speaks on...
Works at Mayo Clinic, Rochester, MN, USA. Features in 1 video on Wondr Medical. Bernard Gersh generally speaks on Dobutamine Stress Echo (DSE), Stable Coronary Artery Disease (CAD), and Positron Emission Tomography (PET).
Works at University of Pittsburgh Medical Center, Pittsburgh, PA, USA. Features in 1 video on Wondr Medical. Conrad...
Works at University of Pittsburgh Medical Center, Pittsburgh, PA, USA. Features in 1 video on Wondr Medical. Conrad Smith generally speaks on Dobutamine Stress Echo (DSE), Stable Coronary Artery Disease (CAD), and Positron Emission Tomography (PET).
A professor of medicine at Stanford University Medical Center, Stanford, CA, USA. Features in 1 video on Wondr...
A professor of medicine at Stanford University Medical Center, Stanford, CA, USA. Features in 1 video on Wondr Medical. David Maron generally speaks on Dobutamine Stress Echo (DSE), Stable Coronary Artery Disease (CAD), and Positron Emission Tomography (PET).
Works at Ferrarotto Hospital, University of Catania, Catania, Sicilia, Italy. Features in 8 videos on Wondr Medical....
Works at Ferrarotto Hospital, University of Catania, Catania, Sicilia, Italy. Features in 8 videos on Wondr Medical. Davide Capodanno generally speaks on Cardiovascular Pharmacotherapy, Cardiac Valves, Covid-19, Covid19 Managing Covid, and Dobutamine Stress Echo (DSE).
Gregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic Affairs for the Mount...
Gregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai in New York, NY. Dr. Stone has served as the national or international principal investigator for more than 120 national and international multicenter randomized trials (many of which have led to new device approval or indications in the US), has authored more than 2000 manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world. With a 2018 H-factor of 152, Dr. Stone was recently listed in Nature Medicine as one of the most prolific authors in science. Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes, myocardial infarction and cardiogenic shock; drug-eluting stents and bioresorbable scaffolds; left main and complex coronary artery disease intervention; antiplatelet and antithrombotic pharmacotherapies; transcatheter valve repair and replacement; interventional hypertension and heart failure therapies; left atrial appendage closure; intravascular imaging (IVUS, OCT and NIRS); vulnerable plaque diagnosis and treatment; adjunctive interventional devices including atherectomy, distal embolic protection, thrombectomy, covered stents, chronic total occlusion devices, and brachytherapy; saphenous vein graft therapies; contrast nephropathy; clinical trial design; and regulatory issues. Dr. Stone is the director of TCT, the world's largest symposium devoted to interventional cardiology and vascular medicine. Dr. Stone founded the annual National Interventional Cardiology Fellow's Course and Transcatheter Valve Therapies TVT), the Chronic Total Occlusion (CTO) Summit, and co-directs multiple other meetings in the US, China, Russia, Europe, S. Korea and elsewhere.
Works at Geisinger Medical Center, Danville, PA, USA. Features in 1 video on Wondr Medical. Kimberly Skelding...
Works at Geisinger Medical Center, Danville, PA, USA. Features in 1 video on Wondr Medical. Kimberly Skelding generally speaks on Dobutamine Stress Echo (DSE), Stable Coronary Artery Disease (CAD), and Positron Emission Tomography (PET).
Manesh Patel is the Chief of the Division of Cardiology and the Division of Clinical Pharmacology. His clinical...
Manesh Patel is the Chief of the Division of Cardiology and the Division of Clinical Pharmacology. His clinical interests include diagnostic and interventional coronary angiography, peripheral angiography and endovascular intervention. His is involved in several clinical trials involving patients with cardiovascular disease and in cardiac imaging. He is also the Chair of the American College of Cardiology Task Force for Appropriate Use Criteria for Cardiovascular Procedures and is Chair of the American Heart Association Diagnostic and Interventional Cath Committee. Patel's interest in cardiac imaging, quality of care, cardiac devices is also evident in his research. His integration of these efforts into his roles at Duke was recognized in 2010 when he received the prestigious Duke Cardiology Fellowship Mentor Award. In 2011, Dr. Patel was named the endowed John Bush Simpson Assistant Professor of Cardiology. In 2013, Dr. Patel received the Robert M. Califf Faculty clinical research Award. Currently, Dr. Patel is leading an effort to redesign the delivery of care to patients undergoing invasive catheterization procedures in the health system with a specific aim of measure and providing individualized, patient centered, innovative, and efficient care.
Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK....
Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK. Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is the lead author of the primary publication in The Lancet. At Imperial College, she is actively involved in the development and recruitment for a number of multi-centre clinical trials. Dr Al- Lamee has over 40 peer-reviewed publications and has presented at international Cardiology conferences worldwide throughout her clinical career. She studied at the University of Oxford and University College London. She went onto complete her training as a junior doctor on the Barts and the London Medical rotation before being appointed as a Specialist Registrar on the North West London Cardiology rotation in 2006. Dr Al-Lamee has twelve years of Cardiology experience and completed three years of Interventional Fellowship training at Hammersmith Hospital in London. She also spent a year training as an Interventional Fellow under the supervision of Professor Antonio Colombo in Milan. She completed specialist training in Cardiology in 2013.
Dr. Bangalore is an interventional cardiologist and a Professor of Medicine at New York University School of...
Dr. Bangalore is an interventional cardiologist and a Professor of Medicine at New York University School of Medicine. He is the Director of Complex Coronary Intervention; Director of Research for the cardiac catheterization laboratory and the Director for the Cardiovascular Outcomes Group. His clinical expertise is in complex coronary intervention including CTOs, ultra low volume/zero contrast PCI, and renal denervation. His research interests are in comparative effectiveness studies for cardiovascular diseases, particularly stable ischemic heart disease, acute coronary syndromes, hypertension and dyslipidemia. Dr. Bangalore has received grants from the National Institutes of Health, Agency for Healthcare Research and Quality, American Heart Association and from the industry. He has published over 350 articles in leading national and international journals including the NEJM, JAMA, Lancet, Circulation and JACC. He is the principal investigator of the ISCHEMIA CKD trial, which is a randomized trial in patients with advanced chronic kidney disease and abnormal stress test, carried out in 33 countries and up to 350 clinical sites. The trial is testing the effectiveness of an initial invasive strategy of cath and revascularization with optimal medical therapy versus a conservative strategy of optimal medical therapy alone in patients with chronic kidney disease. His other areas of interest include comparative effectiveness of coronary artery bypass surgery (CABG) vs. percutaneous coronary intervention (PCI), evaluating the efficacy and safety of various stent types in patients undergoing PCI, including patients with diabetes and those in patients with ST segment elevation myocardial infarction and comparative effectiveness of drug eluting stents vs. bare metal stents. He has won a number of awards including the Dr. Gregory Braden Memorial Interventional Cardiology Fellow of the Year Award from the Society for Cardiovascular Angiography and Intervention and the Douglas P. Zipes Distinguished Young Scientist award from the American College of Cardiology.
Start a conversation